Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
ACTIVE_NOT_RECRUITING
Status
Conditions
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Small Lymphocytic Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Refractory Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- PROCEDURE: Electrocardiogram
- DRUG: Ibrutinib
- DRUG: Lenalidomide
- PROCEDURE: Magnetic Resonance Imaging
- BIOLOGICAL: Rituximab
Sponsor
National Cancer Institute (NCI)